-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Initiates Coverage On Guardant Health with Buy Rating, Announces Price Target of $200

Benzinga·10/23/2026 10:31:48
语音播报
Roth Capital analyst Max Masucci initiates coverage on Guardant Health (NASDAQ:GH) with a Buy rating and announces Price Target of $200.